Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

The document concludes that stem cell inactivity is actively controlled and important for tissue repair and balance.

Runx1 and CDK inhibitors help keep hair follicle stem cells inactive, affecting their future roles.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

EGCG may help regrow hair by inhibiting a specific enzyme.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

CRF can cause hair loss, but blocking its receptors might prevent this.

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

Reducing SOX2 in colorectal cancer cells decreases tumor growth and self-renewal.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Certain substances that block a specific protein help promote hair growth.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

CDK4 levels affect the number of hair follicle stem cells in mice.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.